Skip to content

FARMAFENDER

Active
Private limited companyfounded 200916 yrs activePierlapont 88, 8210 Zedelgem, BelgiumKBO/BCE: BE 0819.991.676
Summary

FARMAFENDER has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €169,514 and a net result of €70,343. Equity is growing by ~64.1% per year across the filed fiscal years. Its solvency ranks better than 74% of 21069 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisWatch ReportCompare
FARMAFENDERActiveChecked score 90/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€269,880total assets 2025
Equity
€169,514
Profit
€70,343
Turnover not published (abridged schema)
Financial health
90 Excellent Checked score 2025
Bankruptcy chance 12 m
0.2%
Structure
Accounts 8 d early0 of 3 deeds read
Why 90- Sector Retail trade (NACE 47)- Size: total assets €269,880+ Founded in 2009+ Equity €169,514 (62.8% of total assets)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Better than 71% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 88-8
equity 62.8% of total assets
Liquidity 41-4
short-term debt 37.2% · cash 6.0%
Profitability 100+2
return on assets 26.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (39,974 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● 0.0% vs 11-2024 01-2025: 0.1%● 0.0% vs 12-2024 02-2025: 0.1%▼ -5.8% vs 01-2025lowest value 03-2025: 0.1%● 0.0% vs 02-2025lowest value 04-2025: 0.1%▲ +13.4% vs 03-2025 05-2025: 0.1%▼ -2.7% vs 04-2025 06-2025: 0.1%▼ -4.7% vs 05-2025 07-2025: 0.1%▲ +24.5% vs 06-2025 08-2025: 0.2%▲ +77.2% vs 07-2025 09-2025: 0.2%● 0.0% vs 08-2025 10-2025: 0.2%● 0.0% vs 09-2025 11-2025: 0.2%● 0.0% vs 10-2025 12-2025: 0.2%● 0.0% vs 11-2025 01-2026: 0.2%▼ -0.4% vs 12-2025 02-2026: 0.2%▲ +5.4% vs 01-2026 03-2026: 0.2%● 0.0% vs 02-2026 04-2026: 0.3%▲ +14.8% vs 03-2026 05-2026: 0.3%▼ -4.1% vs 04-2026 06-2026: 0.3%▼ -1.2% vs 05-2026 07-2026: 0.3%▲ +5.8% vs 06-2026highest value 08-2026: 0.2%▼ -14.7% vs 07-2026 09-2026: 0.2%● 0.0% vs 08-2026 10-2026: 0.2%● 0.0% vs 09-2026
  • Founded in 2009 lowers the probability for this profile
  • Sector Retail trade (NACE 47) raises the probability
  • Equity €169,514 (62.8% of total assets) lowers the probability
  • Size: total assets €269,880 raises the probability for this profile
Credit up to €15,000 at 30 days acceptable
Liquidity ample (current ratio 2.53 against 3.21 in 2024; short-term debt: 37.2% and cash: 6% of total assets), and 37.2% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 75%, liquidity 38%, profitability 96%, growth against the median 75%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Founded in 2009
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
lowers risk · Equity €169,514 (62.8% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Size: total assets €269,880
In the bankruptcy model this factor raises the probability for this profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
8 d early
2024
21 d early
2023
35 d early
2022
14 d early
2021
13 d early
2020
8 d early
2019
20 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 11 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 17 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Highest result since 2018net €70,343 ▲52.8%
  3. Equity above €150,000Eq €169,514 ▲22.7%

Key points

  • Positive: Among the best 8% on net resultsector median €5,049 · 21,046 companies €70,343 View
  • Positive: 8 profitable years in a rowprofit 2025: €70,343 8 years View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€269,880
Profit
€70,343
Solvency
62.8%
Total assets▲ 39.3%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 23-07-2026Annual accounts filed
  2. 31-12-2025Highest result since 2018
  3. 31-12-2025Equity above €150,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
21-10-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure